➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANDROGEL

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Androgel

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00112151	TEAM: Testosterone Supplementation and Exercise in Elderly Men	Completed	National Institute on Aging (NIA)	Phase 2	2005-01-01	The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00112151	TEAM: Testosterone Supplementation and Exercise in Elderly Men	Completed	University of Colorado, Denver	Phase 2	2005-01-01	The purpose of this study is to evaluate the effects of testosterone supplementation (AndroGel) on body composition, strength, endurance, cognition, and function in older men.
NCT00114114	Dose-Response of Gonadal Steroids and Bone Turnover in Men	Recruiting	AbbVie	N/A	2004-09-01	The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur. This information may help determine when to intervene with hormone replacement therapy in aging men.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Androgel

Condition Name

Chart
Table

Condition Name for Androgel
Intervention	Trials
Hypogonadism	10
Secondary Hypogonadism	4
Healthy	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Chart
Table

Condition MeSH for Androgel
Intervention	Trials
Hypogonadism	20
Diabetes Mellitus	4
Prostatic Neoplasms	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Androgel

Trials by Country

Map
Table

Trials by Country for Androgel
Location	Trials
United States	127
Canada	7
Netherlands	2
Germany	2
France	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Map
Table

Trials by US State for Androgel
Location	Trials
New York	12
Texas	11
California	9
Washington	8
Florida	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Androgel

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Androgel
Clinical Trial Phase	Trials
Phase 4	9
Phase 3	9
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Chart
Table

Clinical Trial Status for Androgel
Clinical Trial Phase	Trials
Completed	22
Not yet recruiting	9
Withdrawn	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Androgel

Sponsor Name

Chart
Table

Sponsor Name for Androgel
Sponsor	Trials
Solvay Pharmaceuticals	9
Repros Therapeutics Inc.	4
University of Washington	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Chart
Table

Sponsor Type for Androgel
Sponsor	Trials
Other	31
Industry	26
NIH	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Boehringer Ingelheim

Colorcon

Harvard Business School

AstraZeneca

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.